A Bayesian Framework for Patient-Level Partitioned Survival Cost-Utility Analysis.
Ontology highlight
ABSTRACT: Patient-level health economic data collected alongside clinical trials are an important component of the process of technology appraisal. For end-of-life treatments, the modeling of cost-effectiveness data may involve some form of partitioned survival analysis, in which measures of quality of life and survival for pre- and postprogression periods are combined to generate aggregate measures of clinical benefits (e.g., quality-adjusted survival). In addition, resource use data are often collected and costs are calculated for each type of health service (e.g., treatment, hospital, or adverse events costs). A critical problem in these analyses is that effectiveness and cost data present some complexities, such as nonnormality, spikes, and missingness, which should be addressed using appropriat
SUBMITTER: Gabrio A
PROVIDER: S-EPMC8488644 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA